natriuretic-peptide--c-type and Multiple-Myeloma

natriuretic-peptide--c-type has been researched along with Multiple-Myeloma* in 2 studies

Other Studies

2 other study(ies) available for natriuretic-peptide--c-type and Multiple-Myeloma

ArticleYear
The evaluation of NT-proCNP, C-reactive protein and serum amyloid A protein concentration in patients with multiple myeloma undergoing stem cell transplantation.
    Leukemia research, 2016, Volume: 47

    The importance of proinflamatory cytokines and acute phase proteins in pathogenesis and progression of MM is well known. However, there are any studies evaluating the role of NT-proCN in management and treatment of MM. The aim of our study was to evaluate the concentration of NT-proCNP and acute phase proteins in patients with MM before and after stem cell transplantation. We involved 40 newly diagnosed MM patients in stage III according to the Durie-Salmon classification and treated with high dose of melphalan (200mg/m2) prior to ASCT. Concentration of NT-proCNP, hs-CRP and SAA were measured before conditioning treatment and every 4days until the 24th day after stem cell infusion. We observed low NT-proCNP levels before conditioning treatment (0.121±0.04pmol/l), the higher in day on ASCT (0.28±0.14pmol/l). Further we showed significant gradual increase concentration of NT-proCNP up to 12days after stem cells infusion (1.07±0.72pmol/l). The kinetics of hs-CRP and SAA levels were similar to NT-proCNP. We showed positive correlation between NT-proCNP levels and absolute neutrophil and platelets count in patients after ASCT. NT-proCNP can be useful parameter to assess effectiveness of treatment and monitoring of hematopoetic recovery time in patients with MM after stem cell transplantations.

    Topics: Adult; C-Reactive Protein; Female; Graft Survival; Humans; Male; Middle Aged; Multiple Myeloma; Natriuretic Peptide, C-Type; Neutrophils; Platelet Count; Serum Amyloid A Protein; Stem Cell Transplantation; Time Factors; Transplantation Conditioning

2016
N-terminal pro-C-type natriuretic peptide in serum associated with bone destruction in patients with multiple myeloma.
    Biomarkers in medicine, 2015, Volume: 9, Issue:7

    To examine whether N-terminal proCNP concentrations in serum is associated with bone destruction in patients with multiple myeloma.. N-terminal proCNP and biochemical bone markers were measured in 153 patients. Radiographic bone disease and skeletal-related events were evaluated at specific time-points.. N-terminal proCNP concentrations increased with age. High N-terminal proCNP concentrations were associated with high-risk disease and renal impairment. Renal function explained 22% of the variation. N-terminal proCNP concentrations correlated with serum bone ALP and serum PINP, but lacked association with bone resorption markers, radiographic bone disease and skeletal-related events.. Serum N-terminal proCNP are associated with bone formation activity in patients with multiple myeloma, but should be interpreted with caution in patients with renal impairment.

    Topics: Adult; Aged; Aged, 80 and over; Biomarkers; Bone Diseases; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Myeloma; Natriuretic Peptide, C-Type; Prognosis; Protein Precursors; Radiography

2015